Pfizer warns of risks from its painkiller

Merck had notified the FDA needed an emergency meeting
Baron called to say the drug presented an risk of cardiovascular damage
And researchers voiced their concerns well with drugs as Pfizer s Celebrex
FDA has been aggressive in monitoring drug safety Davis said

The Washington Post had interviewed researchers
But Tom Davis sent a letter to Dr Lester Crawford giving

